-
1.
公开(公告)号:WO2012050623A2
公开(公告)日:2012-04-19
申请号:PCT/US2011/001890
申请日:2011-11-09
发明人: LALEZARI, Iraj , FABRICANT, Jill
IPC分类号: C07C233/00 , C07C217/18 , A61K31/165 , A61P25/28
CPC分类号: C07D307/87 , A61K8/411 , A61K8/42 , A61K8/4926 , A61Q19/08 , C07C215/76 , C07C229/40 , C07C233/75 , C07C235/72 , C07C235/74 , C07C275/34 , C07C275/42 , C07D215/12 , C07D215/14 , C07D215/50 , C07D215/52 , C07D219/04
摘要: The present invention provides a process for the synthesis of substituted phenoxymethylpropionic acid and related compounds. The compounds are useful for inhibiting the formation of AGEs (Advanced Glycation End Products).
摘要翻译: 本发明提供了合成取代的苯氧基甲基丙酸和相关化合物的方法。 这些化合物可用于抑制AGEs(晚期糖基化终产物)的形成。 p>
-
公开(公告)号:WO2012050623A3
公开(公告)日:2012-07-19
申请号:PCT/US2011001890
申请日:2011-11-09
申请人: CELL VIABLE CORP , LALEZARI IRAJ , FABRICANT JILL
发明人: LALEZARI IRAJ , FABRICANT JILL
IPC分类号: C07C233/00 , A61K31/165 , A61P25/28 , C07C217/18
CPC分类号: C07D307/87 , A61K8/411 , A61K8/42 , A61K8/4926 , A61Q19/08 , C07C215/76 , C07C229/40 , C07C233/75 , C07C235/72 , C07C235/74 , C07C275/34 , C07C275/42 , C07D215/12 , C07D215/14 , C07D215/50 , C07D215/52 , C07D219/04
摘要: The present invention provides a process for the synthesis of substituted phenoxymethylpropionic acid and related compounds. The compounds are useful for inhibiting the formation of AGEs (Advanced Glycation End Products).
摘要翻译: 本发明提供了一种合成取代的苯氧基甲基丙酸和相关化合物的方法。 该化合物可用于抑制AGEs(高级糖化终产物)的形成。
-
3.
公开(公告)号:WO01005746A1
公开(公告)日:2001-01-25
申请号:PCT/DK2000/000385
申请日:2000-07-11
IPC分类号: A61K45/00 , A61K31/165 , A61K31/167 , A61K31/197 , A61K31/222 , A61K31/24 , A61P1/04 , A61P9/10 , A61P11/06 , A61P17/00 , A61P17/06 , A61P19/02 , A61P19/06 , A61P29/00 , A61P31/04 , A61P31/18 , A61P37/08 , A61P43/00 , C07C215/16 , C07C225/22 , C07C229/18 , C07C233/43 , C07C233/44 , C07C235/04 , C07C235/10 , C07C235/16 , C07C235/72 , C07C235/74 , C07C237/04 , C07C237/20
CPC分类号: C07C225/22 , C07C229/18 , C07C233/43 , C07C235/10 , C07C235/72 , C07C235/74 , C07C237/20
摘要: The present invention relates to a compound of general formula (I) wherein R1, R2, and R3 represents one or more, same or different substituents selected from the group consisting of halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1-C3)alkyl, (C2-C3)olefinic group, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, cyano, -CONH2, phenyl, or nitro; further R2 can be hydrogen, and R3 can be carboxy and carbamoyl; R4 represents hydrogen, (C1-C3)alkyl, or allyl; X represents oxygen or sulphur; Q represents -(CO)-, -(CS)-, or a bond; Y represents (C5-C15)alkyl; (C2-C15)olefinic group; (C3-C10)monocyclic hydrocarbon group; or phenyl; any of which may be optionally substituted by one or more, same or different substituents selected from the group consisting of the formula R5 defined below; (C1-C4)alkyl substituted by one or more substituents selected for the group R5; or a group of the formula -(Z-O)n-Z, wherein Z is a (C1-C3)alkyl, n is an integer > 1; and no continuous linear sequence of atoms in the group Y exceeds 15; R5 represents halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, cyano, azido, nitro, -COOH, -CONH2, -CONHR', or COONR'R' wherein R' represents (C1-C3)alkyl; or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof. The compounds are valuable in the human and veterinary therapy.
摘要翻译: 本发明涉及通式(I)的化合物,其中R 1,R 2和R 3表示一个或多个相同或不同的选自卤素,羟基,巯基,三氟甲基,氨基,(C 1 -C 3) 烷基,(C2-C3)烯基,(C1-C3)烷氧基,(C1-C3)烷硫基,(C1-C6)烷基氨基,(C1-C3)烷氧基羰基,氰基,-CONH2,苯基或硝基; 另外R2可以是氢,R3可以是羧基和氨基甲酰基; R4表示氢,(C1-C3)烷基或烯丙基; X表示氧或硫; Q表示 - (CO) - , - (CS) - 或键; Y表示(C 5 -C 15)烷基; (C 2 -C 15)烯基; (C 3 -C 10)单环烃基; 或苯基; 其中任何一个可以任选被一个或多个相同或不同的选自以下定义的式R 5的取代基取代; 被一个或多个选自基团R 5的取代基取代的(C 1 -C 4)烷基; 或式 - (Z-O)n-Z的基团,其中Z为(C 1 -C 3)烷基,n为整数> 1; Y组中原子的连续线性序列不超过15; R5表示卤素,羟基,巯基,三氟甲基,氨基,(C1-C3)烷氧基,(C1-C3)烷硫基,(C1-C6)烷基氨基,(C1-C3)烷氧基羰基,氰基,叠氮基,硝基, CONH 2,-CONHR'或COONR'R',其中R'表示(C 1 -C 3)烷基; 或其药学上可接受的盐,或其水合物或溶剂化物。 这些化合物在人类和兽医治疗中是有价值的。
-
-